Literature DB >> 23377185

Natural history of neurofibromatosis type 2 with onset before the age of 1 year.

Martino Ruggieri1, Anna Lia Gabriele, Agata Polizzi, Vincenzo Salpietro, Francesco Nicita, Piero Pavone, Nunzio Platania, Pietro Milone, Angela Distefano, Giuseppe Privitera, Giuseppe Belfiore, Francesca Granata, Rosario Caltabiano, Vincenzo Albanese, Lorenzo Pavone, Aldo Quattrone.   

Abstract

Neurofibromatosis type 2 (NF2) with onset before the first year of life has been anecdotally reported in the literature. We (a) prospectively (years 1997-2012) followed up three unrelated NF2 children, all harbouring NF2 gene mutations whose onset of disease was before age 1 year, and (b) systematically reviewed published reports on NF2 in the youngest age group (i.e. onset <1 year). The present three children had (1) small (<1 cm), bilateral vestibular schwannomas (VSs) detected (as an incidental finding) at magnetic resonance imaging (MRI) by the age of 4 to 5 months that were asymptomatic for 10 to 14 years, with sudden and rapid (<12 months) progression in two cases at the age of 11 and 15 years, respectively; (2) development of large numbers of skin NF2 plaques mainly in atypical locations (i.e. face, hands, legs and knees), which reverted to normal skin appearance at the time of VSs progression; (3) lens opacities (n = 1) and NF2 retinal changes (n = 2) detected as early as age of 3-4 months; (4) diffuse (asymptomatic) high signal lesions at brain MRI in the periventricular regions (alike cortical dysplasia); and (5) unaffected first-degree relatives who did not harbour NF2 gene abnormalities. This represents the youngest NF2 group with the longest prospective follow-up so far reported. NF2 may present as a congenital form with bilateral VSs presenting as early as the first months of life and with natural history different to that which occurs in classical NF2.

Entities:  

Mesh:

Year:  2013        PMID: 23377185     DOI: 10.1007/s10048-013-0354-0

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  16 in total

Review 1.  The clinical and diagnostic implications of mosaicism in the neurofibromatoses.

Authors:  M Ruggieri; S M Huson
Journal:  Neurology       Date:  2001-06-12       Impact factor: 9.910

2.  Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.

Authors:  M Ruggieri; P Iannetti; A Polizzi; I La Mantia; A Spalice; O Giliberto; N Platania; A L Gabriele; V Albanese; L Pavone
Journal:  Neuropediatrics       Date:  2005-02       Impact factor: 1.947

Review 3.  Ohtahara syndrome with emphasis on recent genetic discovery.

Authors:  Piero Pavone; Alberto Spalice; Agata Polizzi; Pasquale Parisi; Martino Ruggieri
Journal:  Brain Dev       Date:  2011-10-02       Impact factor: 1.961

4.  Paediatric presentation of type 2 neurofibromatosis.

Authors:  D G Evans; J M Birch; R T Ramsden
Journal:  Arch Dis Child       Date:  1999-12       Impact factor: 3.791

5.  Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2.

Authors:  Martina M Bosch; Eugen Boltshauser; Paul Harpes; Klara Landau
Journal:  Am J Ophthalmol       Date:  2006-06       Impact factor: 5.258

6.  Central nervous system meningiomas in the first two decades of life: a clinicopathological analysis of 87 patients.

Authors:  Elisabeth J Rushing; Cara Olsen; Hernando Mena; Maria-Eugenia Rueda; Youn-Soo Lee; Robert F Keating; Roger J Packer; Mariarita Santi
Journal:  J Neurosurg       Date:  2005-12       Impact factor: 5.115

7.  [Neurofibromatosis type 2 (NF2). Study of 7 patients].

Authors:  I Pascual-Castroviejo; S I Pascual-Pascual; J Viaño
Journal:  Neurologia       Date:  2009-09       Impact factor: 3.109

8.  Neurofibromatosis 2 in the pediatric age group.

Authors:  V F Mautner; M Tatagiba; R Guthoff; M Samii; S M Pulst
Journal:  Neurosurgery       Date:  1993-07       Impact factor: 4.654

Review 9.  The diagnosis and management of neurofibromatosis 2 in childhood.

Authors:  M MacCollin; V F Mautner
Journal:  Semin Pediatr Neurol       Date:  1998-12       Impact factor: 1.636

10.  A clinical study of type 2 neurofibromatosis.

Authors:  D G Evans; S M Huson; D Donnai; W Neary; V Blair; V Newton; R Harris
Journal:  Q J Med       Date:  1992-08
View more
  14 in total

1.  Neurocutaneous melanocytosis (melanosis).

Authors:  Martino Ruggieri; Agata Polizzi; Stefano Catanzaro; Manuela Lo Bianco; Andrea D Praticò; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2020-10-13       Impact factor: 1.475

2.  Rediagnosing one of Smith's patients (John McCann) with "neuromas tumours" (1849).

Authors:  Martino Ruggieri; Andrea D Praticò; Rosario Caltabiano; Agata Polizzi
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

3.  Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation.

Authors:  Nicolas -Xavier Bonne; Rabih Aboukais; Marc Baroncini; Audrey Hochart; Pierre Leblond; Franck Broly; Frédérique Dubrulle; Jean-Paul Lejeune; Christophe Vincent
Journal:  Childs Nerv Syst       Date:  2016-10-04       Impact factor: 1.475

4.  Options and strategies for hearing restoration in pediatric neurofibromatosis type 2.

Authors:  Hossein Mahboubi; William H Slattery; Gautam U Mehta; Gregory P Lekovic
Journal:  Childs Nerv Syst       Date:  2020-06-21       Impact factor: 1.475

5.  A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.

Authors:  Rosario Caltabiano; Gaetano Magro; Agata Polizzi; Andrea Domenico Praticò; Andrea Ortensi; Valerio D'Orazi; Andrea Panunzi; Pietro Milone; Luigi Maiolino; Francesco Nicita; Gabriele Lorenzo Capone; Roberta Sestini; Irene Paganini; Mariella Muglia; Sebastiano Cavallaro; Salvatore Lanzafame; Laura Papi; Martino Ruggieri
Journal:  Childs Nerv Syst       Date:  2017-04-01       Impact factor: 1.475

6.  Introduction to phacomatoses (neurocutaneous disorders) in childhood.

Authors:  Martino Ruggieri; Agata Polizzi; Gioacchino Paolo Marceca; Stefano Catanzaro; Andrea D Praticò; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2020-09-17       Impact factor: 1.475

Review 7.  A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.

Authors:  Sarah Scollon; Amanda Knoth Anglin; Martha Thomas; Joyce T Turner; Kami Wolfe Schneider
Journal:  J Genet Couns       Date:  2017-03-29       Impact factor: 2.537

8.  Early history of neurofibromatosis type 2 and related forms: earliest descriptions of acoustic neuromas, medical curiosities, misconceptions, landmarks and the pioneers behind the eponyms.

Authors:  Martino Ruggieri; Andrea D Praticò; Agostino Serra; Luigi Maiolino; Salvatore Cocuzza; Rosario Caltabiano; Agata Polizzi
Journal:  Childs Nerv Syst       Date:  2016-09-26       Impact factor: 1.475

9.  Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution.

Authors:  Claire Forde; Andrew T King; Scott A Rutherford; Charlotte Hammerbeck-Ward; Simon K Lloyd; Simon R Freeman; Omar N Pathmanaban; Emma Stapleton; Owen M Thomas; Roger D Laitt; Stavros Stivaros; John-Paul Kilday; Grace Vassallo; Catherine McBain; Simon Kerrigan; Miriam J Smith; Martin G McCabe; Elaine F Harkness; D Gareth Evans
Journal:  Neuro Oncol       Date:  2021-07-01       Impact factor: 12.300

Review 10.  Genomics, Epigenetics, and Hearing Loss in Neurofibromatosis Type 2.

Authors:  Christine T Dinh; Eric Nisenbaum; Darius Chyou; Carly Misztal; Denise Yan; Rahul Mittal; Juan Young; Mustafa Tekin; Fred Telischi; Cristina Fernandez-Valle; Xue-Zhong Liu
Journal:  Otol Neurotol       Date:  2020-06       Impact factor: 2.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.